Stock PYXS PYXIS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Pyxis Oncology, Inc.

Equities

PYXS

US7473241013

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
4.34 USD -3.77% Intraday chart for Pyxis Oncology, Inc. -0.91% +141.11%
03-22 H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating MT
03-21 Health Care Up on Drug Sales Optimism -- Health Care Roundup DJ

Evolution of the average Target Price on Pyxis Oncology, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e2d69.BFB4T-5J1nfC1WHvlxjKRxvaHarQhIHhYpk2FWZ2uuo.dT8cAqgChw6FkxOm1HebBEjqaMiD9tuRJvdcZj9O_IY2ABYqigOiAI2POA~f0c7a501aca97e3a2399f5f0a5422bb0

Analyst Recommendations on Pyxis Oncology, Inc.

H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating MT
BTIG Initiates Pyxis Oncology With Buy Rating, $8 Price Target MT
Leerink Partners Initiates Coverage on Pyxis Oncology with Outperform Rating, $12 Price Target MT
HC Wainwright Starts Pyxis Oncology With Buy Rating, $4 Price Target MT
RBC Initiates Pyxis Oncology at Outperform With Speculative Risk, Sets Price Target at $7, Sees 'Favorable' Risk/Reward MT
Credit Suisse Starts Pyxis Oncology at Outperform with $19 PT on Potential of Antibody-Drug Conjugate for Cancer MT
Jefferies Starts Pyxis Oncology at Buy with $25 Price Target MT
BofA Securities Starts Pyxis Oncology at Neutral With $16 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
4.34 USD
Average target price
8 USD
Spread / Average Target
+84.33%
High Price Target
10 USD
Spread / Highest target
+130.41%
Low Price Target
7 USD
Spread / Lowest Target
+61.29%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Pyxis Oncology, Inc.

HC Wainwright
BTIG
Leerink Partners
RBC Capital Markets
Jefferies & Co.
BofA Securities
Credit Suisse

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PYXS Stock
  4. Consensus Pyxis Oncology, Inc.